Source: Υπουργείο Υγείας (CY) Revision Year: 2014 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Medoril 500mg capsules.
| Pharmaceutical Form |
|---|
|
Capsule. Maroon – pink hard gelatin capsules. For oral administration. |
Each capsule contains 500mg calcium dobesilate.
Excipient with known effect: carmoisine (0.55%/per capsule).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Calcium dobesilate |
Calcium dobesilate is a regulator of capillary functions. Calcium dobesilate acts on the capillary walls by regulating its impaired physiological functions – increased permeability and decreased resistance. It increases erythrocyte flexibility, inhibits platelet hyperaggregation and, in diabetic retinopathy, it reduces plasma and blood hyperviscosity, thus improving blood rheological properties and tissue irrigation. |
| List of Excipients |
|---|
|
Starch pregelatinised |
PVC-Al blisters and PVC-securitainers.
Packs of 30, 60 and 100 capsules are available.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
19893
28/12/2005
| Drug | Countries | |
|---|---|---|
| MEDORIL | Cyprus |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
